Artelo Biosciences, Inc. (ARTL) stock
ARTLNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.68−0.02 (-1.18%)
Close on Nov 17, 2026Market cap $1.13MP/E –Yield –
Artelo Biosciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Artelo Biosciences's enterprise value was -$2.96M on Nov 11, 2026, against $71.36M a year earlier. Over the last 5 years it ranged from -$2.96M to $333.61M, with a median of $106.67M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$2.96M | -106.0% |
| 2025 | Dec 31, 2025 | $49.52M | -43.4% |
| 2024 | Dec 31, 2024 | $87.52M | -18.0% |
| 2023 | Dec 29, 2023 | $106.67M | -9.2% |
| 2022 | Dec 30, 2022 | $117.52M | -64.8% |
| 2021 | Dec 31, 2021 | $333.61M | -77.4% |
| 2020 | Dec 31, 2020 | $1.47B | -59.8% |
| 2019 | Dec 31, 2019 | $3.66B | -43.8% |
| 2018 | Dec 31, 2018 | $6.52B | +42.2% |
| 2017 | Dec 29, 2017 | $4.59B | – |
See a number that looks wrong?